VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,748,000 | -35.5% | 2,200,000 | 0.0% | 3.94% | -32.9% |
Q2 2023 | $52,338,000 | -6.0% | 2,200,000 | +0.5% | 5.88% | -30.6% |
Q1 2023 | $55,704,925 | +94300.7% | 2,189,659 | +8.4% | 8.48% | -4.6% |
Q4 2022 | $59,009 | -99.9% | 2,020,166 | -25.1% | 8.89% | 0.0% |
Q3 2022 | $55,302,000 | +191.7% | 2,696,340 | +64.6% | 8.89% | +121.9% |
Q2 2022 | $18,959,000 | +7.8% | 1,638,609 | +72.2% | 4.01% | +2.0% |
Q1 2022 | $17,590,000 | +5.0% | 951,339 | +12.2% | 3.93% | +1.2% |
Q4 2021 | $16,759,000 | +52.6% | 847,683 | +27.0% | 3.88% | +34.0% |
Q3 2021 | $10,983,000 | +222.2% | 667,674 | +258.2% | 2.90% | +143.8% |
Q2 2021 | $3,409,000 | +9.8% | 186,405 | +0.3% | 1.19% | -3.9% |
Q1 2021 | $3,104,000 | – | 185,781 | – | 1.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |